fbpx

Dengue Fever

Dengue fever is a mosquito-borne tropical disease caused by the dengue virus. Symptoms typically begin three to fourteen days after infection. These may include a high fever, headache, vomiting, muscle and joint pains

Background

male-intro@2x-8
Male age 62

First infection (not diagnosed)

  •  Year & Age of Infection: 1991 at age 34
  • Infected location: Thailand
• Symptoms: High fever for a few days.

Second infection (diagnosed)

  • Year & Age of Infection : 2019 at age 62
  • Infected location: Myanmar
  • Symptoms: High fever, dehydrated, extremely weak & fatigued, no appetite, severe back pain and insomnia.
Dengue Fever BG

Before Receiving Miskawaan Health Group’s Treatment

Client’s Symptoms at Paris on 19 December 2019

  • High fever for 2 days
  • Severe back pain

Treatment Outcome

The condition of Dengue Fever EXACERBATED
Reduction of client’s blood platelet count.
White blood cell count dropped.

19–20 December

  • Insomnia
  • Dehydrated
  • Extremely weak & fatigued
  • No appetite

Diagnosis

20 December

First doctor suspected bacterial infection causing the febrile illness.

21 December
 Second doctor confirmed the diagnosis and medication as prescribed by the first doctor. Conventional Treatment received at Paris

  • Strong Antibiotics
  • Aspirin
  • Paracetamol (“French Tylenol”)
Treating symptoms rather than finding the root causes of the disease.

Following a further deterioration in the client’s condition on 
22 December, the client contacted MHG. Our doctors advised to cease all medication immediately and attend a MHG clinic as soon as possible. Client arrived at MHG in the morning of 24 December to commence immediate treatment.

Diagnosis & Outcomes

Improved total white blood cell by 2.55 fold after 4 days of treatment.

White blood cell (WBC) is part of the immune system to help body to fight against infection by ingesting foreign materials and produce antibodies. ENCYCLOAEDIA BRITANNICA, 2020

Before Treatment – 24 Dec 2019

The normal range of WBC is between 4.5- 10.0* 10^3/ uL. Client’s WBC level is at 2.46*10^3/ul which is 45% less than the minimum reference value.

2nd Day of Treatment – 25 Dec 2019

Client’s WBC level is at 4.01*10^3/ul which is 10.8% less than the minimum reference value.

3rd Day of Treatment – 26 Dec 2019

Client’s WBC level has increased to 5.81^10*3/ul and returned back to normal.

4th Day of Treatment – 26 Dec 2019

Client’s WBC level has increased 2.55 fold to 6.27^10*3/ul and maintain within the normal range.

Improved platelet count by 7.69 fold after treatment.

Platelet Count is the average number of platelet in the blood. It helps the body to heal wounds and prevent excessive bleeding. 
MEDICAL NEWS TODAY, 2019

Before Treatment – 24 Dec 2019

The normal range of platelet count is between 150-450* 10^3/ uL.
Client’s platelet count is at 49*10^3/ul which is 67% less than the minimum reference value.

During Treatment – 27 Dec 2019

Client’s platelet count is at 62*10^3/ul which is 58% less than the minimum reference value.

After Treatment – 02 Jan 2019

Client’s platelet count had increased 7.69 fold to 377^10*3/ul and returned back to normal.

Improved platelet count by 7.69 fold after treatment.

Platelet Count is the average number of platelet in the blood. It helps the body to heal wounds and prevent excessive bleeding. 
MEDICAL NEWS TODAY, 2019

The normal range of platelet count is between 150–450* 10^3/ uL.

Before Treatment – 24 Dec 2019

Client’s platelet count is at 49*10^3/ul which is 67% less than the minimum reference value.

During Treatment – 25–27 Dec 2019

Client’s platelet count had a further drop to 26*10^3/ul and 23*10^3/ul on 25 and 26 December, respectively.

By 27 December, Client’s platelet count raised back to 62*10^3/ul.

After Treatment – 02 Jan 2019

Client’s platelet count had increased 7.69 fold to 377^10*3/ul and returned back to normal.

Treatment & Outcome

Treatment
NO HOSPITALISATION 
during the Dengue Fever 
treatment & recovery 
with MHG.
Outcome

Signs of Rapid Recovery after the 4-day treatment:
Appetite was back on 25 Dec.
Able to attend business meetings on 27 Dec.
Eliminated back pain and insomnia.
Overall improved Client’s total white blood cell by 2.55 fold and met the standard range.
Client’s platelet count increased by 7.69 fold and raised back to normal.

After Treatment


04 Jan – Client was able to resume international travel and normal working hours.
06 Jan – Client returned to gym regime.

Adventist Health (2001) Blood Pressure https://www.twah.org.hk/getimage/index/action/images/name/LMC_-_Blood_Pressure.pdf

Bhatt,S., et al. (2013) The global distribution and burden of dengue. Nature. 496(7446):504-507 https://www.ncbi.nlm.nih.gov/pubmed/23563266

Brady, O.J., et al. (2012) Refining the global spatial limits of dengue virus transmission by evidence-based consensus. PLOS Neglected Tropical Disease. 6(8):e1760 https://www.ncbi.nlm.nih.gov/pubmed/22880140

Encyclopaedia Britannica (2020) White Blood Cell. https://www.britannica.com/science/white-blood-cell

Garcia. G., et al. (2011) Long-term persistence of clinical symptoms in dengue-infected persons and its association with immunological disorder. International Journal of Infectious Disease. 15:e38-43 https://www.ncbi.nlm.nih.gov/pubmed/21112804

Gonzlez, D., et al. (2005) Evaluation of some clinical, humoral and imagological parameters in patients of dengue haemorrhagic fever six months after acute illness. Dengue Bullet. 29:79-84 [online] Available at: https://actascientific.com/ASMI/pdf/ASMI-02-0184.pdf

Medical News Today (2019) What do high or low platelet count level mean. https://www.medicalnewstoday.com/articles/322726.php#mpv-count-is-high

NHS (2017) Hypothermia. https://www.nhs.uk/conditions/hypothermia/

Rathnasiri Bandara, SMR., et al. (2019) Management of dengue and post dengue complication syndrome: A review. ACTA scientific microbiology. 2:2581-3226 https://actascientific.com/ASMI/pdf/ASMI-02-0184.pdf

World Health Organisation (2019) Dengue and severe dengue. https://www.who.int/news-room/fact-sheets/detail/dengue-and-severe-dengue

Advanced Cancer Research (2003) Natural killer cells and cancer
https://www.ncbi.nlm.nih.gov/pubmed/14710949

American Cancer Society (2016) Viruses that can lead to cancer
https://www.cancer.org/cancer/cancer-causes/infectious-agents/infections-that-can-lead-to-cancer/viruses.html

Billett, H.H. (1990) Haemoglobin and haematocrit. Clinical methods: the history, physical, and laboratory examinations
https://www.ncbi.nlm.nih.gov/books/NBK259/

Campo, E., Swerdlow, S.H., Harris, N.L., Pileri, S., Stein, H., Jaffe, E.S. (2011) The 2008 WHO classification of lymphoid neoplasms and beyond: evolving concepts and practical applications. Journal of American Society of Hematology. 117(19):5019-5032
https://www.ncbi.nlm.nih.gov/pmc/articles/
PMC3109529/#

Coy, J.F. (2017) EDIM-TKTL1/Apo10 blood test: an innate immune system based liquid biopsy for the early detection, characterization and targeted treatment of cancer. International Journal of Molecular Sciences. 20:18(4)
https://www.ncbi.nlm.nih.gov/pubmed/28425973

Encyclopaedia Britannica (2019) Neurotransmitter
https://www.britannica.com/science/
neurotransmitter

Ginaldi, L., Martinis, M.D., Matutes, E., Farahat, N., Morilla, R., Catovsky, D. (1998) Levels of expression of CD19 and CD20 in chronic B cell leukaemias. Journal Clinica of Pathology. 51:364-369
https://www.ncbi.nlm.nih.gov/pmc/articles/
PMC500695/pdf/jclinpath00266-0020.pdf

Grimm, M., Schmitt, S., Teriete, P., Biegner, T., Stenzl, A., Hennenlotter, J., Muhs, H.J., Munz, A., Nadtotschi, T., Konig, K., Sanger, J., Feyen, O., Hofmann, H., Reinert, S., Coy, J.F. (2013) A biomarker based detection and characterization of carcinomas exploiting two fundamental biophysical mechanisms in mammalian cells. BMC Cancer. 4:13:569 https://www.ncbi.nlm.nih.gov/pubmed/24304513

Ko, Y.H. (2015) EBV and human cancer. Experimental & Molecular Medicine. 47(1):e130 https://www.ncbi.nlm.nih.gov/pmc/articles/
PMC4314581/

Lange, C.A.K, Tisch-Rottensteiner, J., Bohringer, D., Gottfried, M., Schwartzkopff, J., Auw-Hadrich, C. (2012) Enhanced TKTL1 expression in malignant tumours of the ocular adnexa predicts clinical outcome. Ophthalmology. 119(9):1924- 9
https://www.ncbi.nlm.nih.gov/pubmed/22658715

Madu, A.J., Ocheni, S., Ibegbulam, OG., Aguwa, E.N., Madu, K.A. (2013) Pattern of CD4 T-lymphocyte values in cancer patients on cytotoxic therapy. Annals of Medical and Health Science Research. 3(4):498-503
https://www.ncbi.nlm.nih.gov/pmc/articles/
PMC3868113/

Martel, J. (2018) Healthline: T cell count
https://www.healthline.com/health/t-cell-count

National Cancer Institute (2018) NCI Dictionary of Cancer Terms- cancer

https://www.cancer.gov/publications/
dictionaries/cancer-terms/def/cancer

National Cancer Institute (2018) NCI Dictionary of Cancer Terms – complete blood count
https://www.cancer.gov/publications/
dictionaries/cancer-terms/def/complete-blood-count

National Cancer Institute (2018) NCI Dictionary of Cancer Terms – malignancy
https://www.cancer.gov/publications/
dictionaries/cancer-terms/def/malignancy

National Cancer Institute (2018) NCI Dictionary of Cancer Terms – thrombocytes
https://www.cancer.gov/publications/
dictionaries/cancer-terms/def/thrombocyte

National Kidney Foundation (2017) Creatinine: what is it?
https://www.kidney.org/atoz/content/what-creatinine

Ollila, J. & Vihinen, M (2005) B cells. The International Journal of Biochemistry & Cell Biology. 37(3):518-23
https://www.ncbi.nlm.nih.gov/pubmed/
15618007

Thompson, M.P. & Kurzrock, R. (2004) Epstein-Barr virus and cancer. Clinical Cancer Research. 10(3):803-21 https://www.ncbi.nlm.nih.gov/pubmed/
14871955

Troussard, X., Cornet, E. (2017) Hairy cell leukemia 2018: update on diagnosis, risk stratification, and treatment. American Journal of Hematology 92(12):1382-1390
https://www.ncbi.nlm.nih.gov/pmc/articles/
PMC5698705/

Wu, J., Lanier, L.L. (2003) Natural killer cells and cancer. Advances in Cancer Research. 90:127-56 https://www.ncbi.nlm.nih.gov/pubmed/
14710949

University of Rochester Medical Center (2019) What are red blood cells?
https://www.urmc.rochester.edu/encyclopedia/
content.aspx?ContentID=34&ContentTypeID=160

Vazzana, N., Spadano, R., Sestili, S., Toto, V., Falorio, S., Catinella, V., Angrilli, F., Dragani, A. (2004) Hairy cell leukaemia and venous thromboembolism: a case report and review of the literature. Blood Transfusion. 12(2):276- 279
https://www.ncbi.nlm.nih.gov/pmc/articles/
PMC4039712/

Viver, E., Tomasello, E., Baratin, M., Walzer, T., Ugolini, S. (2008) Functions of natural killer cells. Nature Immunology. 9(5):503-10
https://www.ncbi.nlm.nih.gov/pubmed/
18425107

* The case studies of PRAXISKLINIK AM SCHLOSSPARK/Miskawaan Health Group represent carefully & individually assessed clients’ treatments following extensive testing – they are only to be used as examples of treatments and not as a guideline for treatment.
Scroll to Top